Skip to main navigation
Skip to search
Skip to main content
University of Haifa Home
Update your profile
Link opens in a new tab
Search content at University of Haifa
Home
Researchers
Research units
Research output
A global action agenda for turning the tide on fatty liver disease
Healthy Livers, Healthy Lives Collaborators
School of Public Health
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A global action agenda for turning the tide on fatty liver disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fatty Liver Disease
100%
Global Action
100%
Models of Care
28%
Action Priority
28%
Living with
14%
Qualtrics
14%
High Prevalence
14%
Public Policy
14%
Healthcare Professionals
14%
Politicians
14%
Early Diagnosis
14%
Liver
14%
Disease Prevention
14%
Communities of Practice
14%
4-point
14%
Health Outcomes
14%
Primary Care Physicians
14%
Written Feedback
14%
Patient Perspective
14%
Clinical Investigator
14%
Public Health Risk
14%
Treatment Model
14%
Multiple Morbidity
14%
Disease Treatment
14%
Non-communicable Diseases
14%
Preventive Treatment
14%
Public Health Policy
14%
AIMS™
14%
Community Perspectives
14%
Delphi Method
14%
Preventive Care
14%
Likert Scale
14%
Community Leadership
14%
Epidemiological Model
14%
Disease Community
14%
Specialty Care
14%
Individual Priorities
14%
Public Health Experts
14%
Medicine and Dentistry
Fatty Liver
100%
Public Health
28%
Prevalence
28%
Cohort Effect
14%
Early Diagnosis
14%
Awareness
14%
Primary Health Care
14%
Non Communicable Disease
14%
Health Outcomes
14%
Public Health Policy
14%
Likert Scale
14%
Specialist Care
14%
Multiple Morbidities
14%
Nursing and Health Professions
Fatty Liver
100%
Prevalence
28%
Nutrition Policy
28%
Health Outcomes
14%
General Practitioner
14%
Health Care Policy
14%
Model of Care
14%
Likert Scale
14%
Non Communicable Disease
14%
Hepatologist
14%
Early Diagnosis
14%
Specialist Care
14%
Veterinary Science and Veterinary Medicine
Fatty Liver
100%
Prevalence
28%
Communicable Disease
14%